Please use this identifier to cite or link to this item:
https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/7952
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | D. Kamalaveni | - |
dc.contributor.author | S. Kalaiselvi | - |
dc.date.accessioned | 2024-02-27T06:23:14Z | - |
dc.date.available | 2024-02-27T06:23:14Z | - |
dc.date.issued | 2010 | - |
dc.identifier.uri | http://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/7952 | - |
dc.description.abstract | Today, the Indian Pharmaceutical industry is in the front rank of India's science - based industries with wide ranging capabilities in the complex field of drug manufacturing and technology. As a highly organized sector, the Indian pharma industry is estimated to be worth $4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. | - |
dc.publisher | Indian Journal of Finance | - |
dc.title | Determinants of Dividend in Indian Pharmaceutical Industry - A study of Select Companies | - |
dc.vol | Vol 4 | - |
dc.issued | No 3 | - |
Appears in Collections: | Articles to be qced |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Determinants of Dividend In Indian Pharmaceutical Industry.pdf Restricted Access | 1.64 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.